Total Pharmaceuticals industry deals worth $5.7bn were announced globally for August 2022, with Bain Capital's $3.12bn private equity deal with Evident being the sector's biggest investment, according to GlobalData's deals database.

The value marked a decrease of 39.5% over the earlier month of $9.36bn and a drop of 54.7% when compared with the last 12-month average of $12.48bn.

In terms of number of deals, the sector saw a drop of 21.89% with 157 deals in August 2022 when compared to the last 12-month average of 201 deals.

For more Pharma M&A Deals therapy area insights, download a free sample

In value terms, Asia-Pacific drove the activity with deals worth $3.35bn in August 2022.

Medical Devices industry deals in August 2022: Top deals

The top five deals accounted for 76.2% of the overall value during August 2022.

The combined value of the top five deals stood at $4.31bn, against the overall value of $5.7bn recorded for the month.

The top five medical devices industry deals of August 2022 tracked by GlobalData were:

1) Bain Capital's $3.12bn private equity deal with Evident

2) The $468.22m acquisition of B Medical Systems by Azenta

3) Teleflex's $300m acquisition deal with Standard Bariatrics

4) The $250m acquisition of Biorez by ConMed

5) Bio-Rad Laboratories' $170m acquisition deal with Curiosity Diagnostics

Comments

Popular posts from this blog

Telco STC Saudi Arabia attracts more than four million users to its STC Pay mobile wallet

Slovenia to file lawsuit against European Commission over Teran grape trade dispute

Facing strong economic headwinds